| 2025 |
Crystal structures of the Nir2 C-terminal LNS2 domain bound to phosphatidic acid (PA) reveal that residues S1025, T1065, K1103, and K1126 form hydrogen bonds with the phosphate headgroup of PA, conferring PA-sensing specificity; a salt bridge between E355 in Nir2 and R55 in VAPB mediates the FFAT–VAPB interaction; and the central DDHD domain forms a twofold symmetric dimer that stabilizes membrane association at ER-PM contact sites. |
X-ray crystallography (three crystal structures) with mutagenesis and functional validation |
Proceedings of the National Academy of Sciences of the United States of America |
High |
41129229
|
| 2013 |
Following receptor-induced Ca2+ signaling, E-Syt1 translocates to ER-PM junctions in a Ca2+-dependent manner to enhance ER-to-PM connection, which subsequently facilitates recruitment of Nir2 to ER-PM junctions; Nir2 then replenishes PM PIP2 via its phosphatidylinositol transfer protein (PITP) activity. |
Genetically encoded ER-PM junction marker, live-cell imaging, knockdown with PIP2 replenishment assay, Ca2+ signaling measurements |
Cell reports |
High |
24183667
|
| 2015 |
Nir2 functions as a bidirectional lipid exchanger at ER-PM contact sites: it transfers phosphatidylinositol (PtdIns) from the ER to the PM and transfers phosphatidic acid (PtdOH) in the reverse direction (PM to ER), coupling PI(4,5)P2 utilization with PtdIns resynthesis to maintain signaling competence; in Nir2-depleted cells, PtdOH accumulates at the PM and PtdIns synthesis is severely impaired. |
Lipid transfer assays, Nir2 depletion (RNAi) with lipid mass spectrometry, PLC activation studies, live-cell imaging of lipid sensors |
Developmental cell |
High |
26028218
|
| 2015 |
Nir2 detects PIP2 hydrolysis and translocates to ER-PM junctions via binding to phosphatidic acid through its C-terminal region; ER membrane PI is required for rapid PM PIP2 replenishment; Nir2 and its homolog Nir3 differentially regulate PIP2 homeostasis—Nir2 responds to intense stimulation while Nir3 maintains resting-state PIP2 levels. |
PA-binding assays, dominant-negative and knockdown approaches, live-cell imaging of PIP2 sensors, ER PI depletion experiments |
The Journal of biological chemistry |
High |
25887399
|
| 2005 |
Nir2 is a peripheral Golgi protein essential for maintaining DAG levels in the Golgi apparatus; its depletion by RNAi reduces Golgi DAG and blocks protein transport from the trans-Golgi network to the plasma membrane; inhibition of the CDP-choline pathway for phosphatidylcholine biosynthesis rescues both defects, indicating Nir2 regulates DAG homeostasis by controlling its consumption via the CDP-choline pathway. |
RNAi knockdown, DAG quantification in Golgi, vesicular transport assay, CDP-choline pathway inhibition rescue experiment |
Nature cell biology |
High |
15723057
|
| 2004 |
At mitosis onset, Cdk1 phosphorylates Nir2 at multiple sites, most prominently S382, causing its dissociation from the Golgi apparatus; phospho-Nir2(pS382) localizes to the cleavage furrow and midbody during cytokinesis and serves as a docking site for the Polo box domain (PBD) of Plk1; a Nir2 mutant unable to bind Plk1 impairs cytokinesis completion. |
In vitro kinase assay, phospho-site mutagenesis, immunolocalization, overexpression of binding-deficient mutant, co-immunoprecipitation of Plk1 PBD |
Molecular cell |
High |
15125835
|
| 2013 |
Nir2 translocates from the Golgi to the plasma membrane in response to growth factor stimulation; this translocation is triggered by PA formation and mediated by the C-terminal PA-binding region of Nir2; Nir2 depletion substantially reduces PM PI(4,5)P2 levels and growth factor-stimulated PI(3,4,5)P3 production, and attenuates MAPK and PI3K/AKT pathway activation. |
PA-binding assay (in vitro), growth factor stimulation + live imaging, RNAi knockdown with PI(4,5)P2 and PI(3,4,5)P3 sensors, signaling pathway readouts |
EMBO reports |
High |
23897088
|
| 2002 |
Nir2 is essential for cytokinesis: microinjection of anti-Nir2 antibodies blocks cytokinesis, producing multinucleate cells; Nir2 translocates from the Golgi to the cleavage furrow and midbody during cytokinesis, colocalizes with RhoA, and associates with RhoA in mitotic cells; its N-terminal region containing a Rho-inhibitory domain (Rid) is required for cytokinesis completion. |
Antibody microinjection, time-lapse videomicroscopy, immunolocalization, co-immunoprecipitation with RhoA, dominant-negative overexpression |
Molecular and cellular biology |
High |
12077336
|
| 2002 |
Nir2 contains a Rho-inhibitory domain (Rid) with sequence homology to formin-homology Rho-binding sites; Rid preferentially binds the inactive GDP-bound form of RhoA, inhibits Rho-mediated stress fiber formation and LPA-induced RhoA activation; microinjection of anti-Nir2 antibodies into neuronal cells attenuates neurite extension, whereas Nir2 overexpression attenuates Rho-mediated neurite retraction. |
Biochemical GTPase-binding assays, stress fiber and actin staining, antibody microinjection, overexpression in neuronal cells |
Molecular and cellular biology |
Medium |
11909959
|
| 2002 |
A T59E mutation in the PI-transfer domain of Nir2 targets the protein to lipid droplets; the PI-transfer domain alone (T59E) is sufficient for lipid droplet targeting; oleic acid treatment induces wild-type Nir2 (but not T59A) translocation to lipid droplets; this targeting is attributed to enhanced threonine phosphorylation at position 59. |
Site-directed mutagenesis, Nile red lipid droplet staining, live-cell imaging, oleic acid treatment, phosphorylation analysis |
Current biology |
Medium |
12225667
|
| 2016 |
Nir2 localizes to ER-PM contact zones via interaction of its FFAT domain with ER-bound VAP-A and VAP-B; following PLC activation, Nir2 also binds the PM via interaction of its C-terminal domains with DAG and PtdOH; VAP-B mutations linked to familial ALS cause VAP-B aggregation and impair its binding to Nir2. |
Co-immunoprecipitation, lipid-binding assays, live-cell imaging, dominant-negative mutant analysis |
Biochemical Society transactions |
Medium |
26862206
|
| 2019 |
Nir2 acts as an effector of VAMP-associated proteins (VAPA and VAPB) to support HCV replication; Nir2 replenishes phosphoinositides (PI) at the HCV replication organelle to maintain elevated PI(4)P levels consumed by OSBP, completing a PI/PA exchange cycle between the ER and the viral replication organelle. |
Nir2 knockdown/knockout with HCV replication assays, PI(4)P sensor imaging, co-immunoprecipitation with VAPs |
Journal of virology |
Medium |
31484747
|
| 2023 |
PITPNM1 (Nir2) and PITPNM2 (Nir3) accumulate on ER cisternae juxtaposed to phagocytic cups and maintain PI(4,5)P2 homeostasis at phagocytic cups; CRISPR-Cas9 double knockout of Nir2/3 decreases PM PI(4,5)P2, reduces actin ring density at particle capture sites, stalls phagocytosis at the cup stage, and causes repetitive abortive phagosome closure events. |
CRISPR-Cas9 knockout, PI(4,5)P2 sensors, live-cell imaging, phagocytosis assays, actin imaging, re-expression rescue |
Journal of cell science |
High |
37376972
|
| 2022 |
Nir1 constitutively localizes at ER-PM junctions and promotes Nir2 recruitment to ER-PM junctions during receptor-mediated signaling via a direct protein–protein interaction between Nir1 and a region between the FFAT motif and the DDHD domain of Nir2, thereby facilitating efficient PM PIP2 replenishment. |
Live-cell imaging, biochemical co-immunoprecipitation, knockdown/rescue experiments, PIP2 sensor measurements |
Molecular biology of the cell |
Medium |
35020418
|
| 2025 |
Nir2 knockdown in HUVECs inhibits angiogenic tube formation, reduces cell viability, proliferation and migration, diminishes actin stress fibers, and decreases AKT and ERK signaling upon VEGF stimulus; co-immunoprecipitation and co-localization confirmed that Nir2 interacts with VAPA at membrane contact sites. |
siRNA knockdown, angiogenesis tube formation assay, proliferation/migration assays, shRNA-resistant rescue, co-immunoprecipitation, proximity ligation |
Biochimica et biophysica acta. Molecular cell research |
Medium |
40010513
|
| 2014 |
Nir2 enhances epithelial-mesenchymal transition (EMT) in mammary epithelial and breast cancer cells; Nir2 depletion attenuates growth factor-induced cell migration and invasion; effects on EMT are mediated through the PI3K/AKT and ERK1/2 pathways; Nir2 depletion inhibits lung metastasis in animal models. |
shRNA knockdown, EMT marker quantification, migration/invasion assays, PI3K/AKT and ERK pathway readouts, in vivo metastasis model |
Journal of cell science |
Medium |
25179602
|
| 2013 |
Pitpnm1 is expressed in inner hair cells of the organ of Corti from late embryonic stages to adulthood and transiently in outer hair cells postnatally, but Pitpnm1 null mice show no hearing defects, indicating functional redundancy with Pitpnm2 and Pitpnm3. |
In situ hybridization/expression analysis, Pitpnm1 knockout mouse audiometry (ABR) |
Neuroscience |
Medium |
23820044
|